JPS4945079A - - Google Patents

Info

Publication number
JPS4945079A
JPS4945079A JP48089355A JP8935573A JPS4945079A JP S4945079 A JPS4945079 A JP S4945079A JP 48089355 A JP48089355 A JP 48089355A JP 8935573 A JP8935573 A JP 8935573A JP S4945079 A JPS4945079 A JP S4945079A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP48089355A
Other languages
Japanese (ja)
Other versions
JPS5626660B2 (enExample
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4945079A publication Critical patent/JPS4945079A/ja
Publication of JPS5626660B2 publication Critical patent/JPS5626660B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP8935573A 1972-08-12 1973-08-10 Expired JPS5626660B2 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2239815A DE2239815C2 (de) 1972-08-12 1972-08-12 2-Alkylamino-dihydropyridine, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
JPS4945079A true JPS4945079A (enExample) 1974-04-27
JPS5626660B2 JPS5626660B2 (enExample) 1981-06-19

Family

ID=5853453

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8935573A Expired JPS5626660B2 (enExample) 1972-08-12 1973-08-10

Country Status (29)

Country Link
US (1) US3959292A (enExample)
JP (1) JPS5626660B2 (enExample)
KR (1) KR780000072B1 (enExample)
AT (1) AT327194B (enExample)
AU (1) AU469267B2 (enExample)
BE (1) BE803474A (enExample)
BG (1) BG22816A3 (enExample)
CA (1) CA1016945A (enExample)
CH (1) CH583196A5 (enExample)
CS (1) CS178892B2 (enExample)
DD (1) DD109627A5 (enExample)
DE (1) DE2239815C2 (enExample)
DK (1) DK136062C (enExample)
ES (1) ES417807A1 (enExample)
FI (1) FI55998C (enExample)
FR (1) FR2195450B1 (enExample)
GB (1) GB1384219A (enExample)
HU (1) HU167991B (enExample)
IE (1) IE37989B1 (enExample)
IL (1) IL42933A (enExample)
LU (1) LU68206A1 (enExample)
NL (1) NL7311031A (enExample)
NO (1) NO139130C (enExample)
PL (1) PL89396B1 (enExample)
RO (1) RO62914A (enExample)
SE (1) SE386164B (enExample)
SU (1) SU475772A3 (enExample)
YU (1) YU36172B (enExample)
ZA (1) ZA735460B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS643065A (en) * 1987-03-20 1989-01-06 Sandvik Ab Oxide-base ceramic cutting insert

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639257A1 (de) * 1976-09-01 1978-03-02 Bayer Ag Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4442100A (en) * 1979-12-11 1984-04-10 Bayer Aktiengesellschaft Substituted 2-amino-3,4-dihydropyridine derivatives, their production and their medicinal use
DE3134945A1 (de) * 1981-09-03 1983-03-17 Bayer Ag, 5090 Leverkusen Substituierte 2-amino-3,4-dihydropyridinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimittel
ATE50987T1 (de) * 1982-05-10 1990-03-15 Takeda Chemical Industries Ltd Dihydropyridinderivate, deren herstellung und verwendung.
US4603135A (en) * 1983-10-17 1986-07-29 Takeda Chemical Industries, Ltd. Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates
US4678796A (en) * 1984-11-30 1987-07-07 Warner-Lambert Company 2-alkylidene derivatives of 1,2,3,4-tetrahydropyridine-2,5-pyridine carboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
CA1267416A (en) 1985-06-17 1990-04-03 Ila Sircar 1,4-dihydropyridine derivatives useful for the treatment of cardiovascular disorders
US4732898A (en) * 1986-04-29 1988-03-22 Warner-Lambert Company 2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
JPWO2019124203A1 (ja) 2017-12-22 2020-10-22 東レ株式会社 テープ状プリプレグ及びその製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS643065A (en) * 1987-03-20 1989-01-06 Sandvik Ab Oxide-base ceramic cutting insert

Also Published As

Publication number Publication date
DK136062C (da) 1978-01-09
FR2195450B1 (enExample) 1977-09-09
ATA707073A (de) 1975-04-15
FI55998C (fi) 1979-11-12
RO62914A (fr) 1977-11-15
KR780000072B1 (en) 1978-03-30
LU68206A1 (enExample) 1973-10-16
FR2195450A1 (enExample) 1974-03-08
YU213373A (en) 1981-06-30
IE37989B1 (en) 1977-11-23
ES417807A1 (es) 1976-03-01
DK136062B (da) 1977-08-08
YU36172B (en) 1982-02-25
DE2239815C2 (de) 1983-02-10
DD109627A5 (enExample) 1974-11-12
CH583196A5 (enExample) 1976-12-31
GB1384219A (en) 1975-02-19
DE2239815A1 (de) 1974-02-21
IE37989L (en) 1974-02-12
US3959292A (en) 1976-05-25
SU475772A3 (ru) 1975-06-30
IL42933A (en) 1977-04-29
CS178892B2 (en) 1977-10-31
ZA735460B (en) 1974-07-31
NO139130C (no) 1979-01-10
FI55998B (fi) 1979-07-31
CA1016945A (en) 1977-09-06
BG22816A3 (bg) 1977-04-20
AU469267B2 (en) 1976-02-05
IL42933A0 (en) 1973-11-28
BE803474A (fr) 1974-02-11
JPS5626660B2 (enExample) 1981-06-19
AU5912473A (en) 1975-02-13
PL89396B1 (enExample) 1976-11-30
HU167991B (enExample) 1976-02-28
NO139130B (no) 1978-10-02
NL7311031A (enExample) 1974-02-14
SE386164B (sv) 1976-08-02
AT327194B (de) 1976-01-26

Similar Documents

Publication Publication Date Title
FR2195450B1 (enExample)
CS158170B2 (enExample)
JPS4949898U (enExample)
JPS48105049U (enExample)
JPS4983221A (enExample)
JPS5016566Y1 (enExample)
JPS4949427U (enExample)
CS151840B1 (enExample)
JPS49100819U (enExample)
CS156805B1 (enExample)
CS160307B1 (enExample)
CS160339B1 (enExample)
CS156588B1 (enExample)
CS154184B1 (enExample)
CS157307B1 (enExample)
CS152690B1 (enExample)
CH1468072A4 (enExample)
CH593300A5 (enExample)
CH588722A5 (enExample)
BG18637A1 (enExample)
BG17922A1 (enExample)
CH572951A5 (enExample)
CH568120A5 (enExample)
CH566403A5 (enExample)
CH569197A5 (enExample)